title: "Time sweet time": circadian characterization of galectin-1 null mice.
abstract: BACKGROUND
  Recent evidence suggests a two-way interaction between the immune and circadian systems. Circadian control of immune factors, as well as the effect of immunological variables on circadian rhythms, might be key elements in both physiological and pathological responses to the environment. Among these relevant factors, galectin-1 is a member of a family of evolutionarily-conserved glycan-binding proteins with both extracellular and intracellular effects, playing important roles in immune cell processes and inflammatory responses. Many of these actions have been studied through the use of mice with a null mutation in the galectin-1 (Lgals1) gene. To further analyze the role of endogenous galectin-1 in vivo, we aimed to characterize the circadian behavior of galectin-1 null (Lgals1-/-) mice.
  
  
  METHODS
  We analyzed wheel-running activity in light-dark conditions, constant darkness, phase responses to light pulses (LP) at circadian time 15, and reentrainment to 6 hour shifts in light-dark schedule in wild-type (WT) and Lgals1-/- mice.
  
  
  RESULTS
  We found significant differences in free-running period, which was longer in mutant than in WT mice (24.02 vs 23.57 h, p < 0.005), phase delays in response to LP (2.92 vs 1.90 circadian h, p < 0.05), and also in alpha (14.88 vs. 12.35 circadian h, p < 0.05).
  
  
  CONCLUSIONS
  Given the effect of a null mutation on circadian period and entrainment, we indicate that galectin-1 could be involved in the regulation of murine circadian rhythmicity. This is the first study implicating galectin-1 in the mammalian circadian system.
authors.affiliation: Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes/CONICET, Argentina. dgolombek@unq.edu.ar.
authors.forename: Leandro P
authors.initials: LP
authors.lastname: Casiraghi
authors.forename: Diego O
authors.initials: DO
authors.lastname: Croci
authors.forename: Francoise
authors.initials: F
authors.lastname: Poirier
authors.forename: Gabriel A
authors.initials: GA
authors.lastname: Rabinovich
authors.forename: Diego A
authors.initials: DA
authors.lastname: Golombek
references.citation: Development. 1993 Dec;119(4):1229-36
references.pmid: 8306885
references.citation: Cancer Cell. 2004 Mar;5(3):241-51
references.pmid: 15050916
references.citation: J Mol Neurosci. 2002 Feb-Apr;18(1-2):105-9
references.pmid: 11931340
references.citation: Nat Rev Immunol. 2009 May;9(5):338-52
references.pmid: 19365409
references.citation: Nat Med. 2007 Dec;13(12):1450-7
references.pmid: 18026113
references.citation: Brain Res Dev Brain Res. 1999 Nov 18;117(2):171-8
references.pmid: 10567735
references.citation: Glycobiology. 2006 Nov;16(11):137R-157R
references.pmid: 16840800
references.citation: Cell Mol Biol Lett. 2009;14(1):128-38
references.pmid: 18850073
references.citation: Proc Soc Exp Biol Med. 1960 Jan;103:142-4
references.pmid: 14398944
references.citation: Nat Rev Cancer. 2005 Jan;5(1):29-41
references.pmid: 15630413
references.citation: Neurosci Lett. 2004 Mar 18;358(1):9-12
references.pmid: 15016422
references.citation: J Neurobiol. 2000 Dec;45(4):195-206
references.pmid: 11077424
references.citation: Cell Death Differ. 2009 Mar;16(3):417-27
references.pmid: 19008923
references.citation: Nat Immunol. 2009 Sep;10(9):981-91
references.pmid: 19668220
references.citation: Chronobiol Int. 1999 Sep;16(5):581-622
references.pmid: 10513884
references.citation: Shock. 1999 Aug;12(2):118-26
references.pmid: 10446892
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12843-8
references.pmid: 17646651
references.citation: Physiol Rev. 2010 Jul;90(3):1063-102
references.pmid: 20664079
references.citation: Nat Immunol. 2008 Jun;9(6):593-601
references.pmid: 18490910
references.citation: J Biol Rhythms. 2008 Apr;23(2):150-9
references.pmid: 18375864
references.citation: Brain Res. 2008 Sep 26;1232:104-12
references.pmid: 18703032
references.citation: Infect Immun. 1999 Dec;67(12):6603-10
references.pmid: 10569781
references.citation: J Neurosci Res. 2006 Nov 15;84(7):1521-7
references.pmid: 16955486
references.citation: J Immunol. 1997 Jun 1;158(11):5163-8
references.pmid: 9164932
references.citation: Int Arch Allergy Immunol. 2005 Apr;136(4):385-400
references.pmid: 15775687
references.citation: Chronobiol Int. 2009 Oct;26(7):1430-42
references.pmid: 19916840
references.citation: J Neurosci. 2005 Jan 12;25(2):404-8
references.pmid: 15647483
references.citation: Neuroscience. 2003;118(1):253-61
references.pmid: 12676155
references.citation: Expert Rev Mol Med. 2008 Jun 13;10:e17
references.pmid: 18549522
references.citation: J Neurochem. 2007 Jun;101(5):1214-23
references.pmid: 17403142
references.citation: Curr Drug Targets. 2005 Jun;6(4):419-25
references.pmid: 16026260
references.citation: Dev Biol. 1996 Oct 10;179(1):274-87
references.pmid: 8873770
references.citation: Exp Neurol. 2007 Oct;207(2):302-13
references.pmid: 17706645
references.citation: Langenbecks Arch Surg. 2001 Mar;386(2):132-40
references.pmid: 11374046
references.citation: Nat Immunol. 2007 Aug;8(8):825-34
references.pmid: 17589510
references.citation: Nat Neurosci. 2007 Jun;10(6):712-9
references.pmid: 17486104
references.citation: Neurosci Lett. 2000 Jul 21;288(3):228-30
references.pmid: 10889349
references.citation: Eur Surg Res. 2002 Jan-Apr;34(1-2):22-9
references.pmid: 11867897
references.citation: Neuroreport. 1994 Feb 24;5(6):712-4
references.pmid: 8199344
references.citation: Proc Natl Acad Sci U S A. 2006 May 2;103(18):7112-7
references.pmid: 16636291
references.citation: J Neuroimmunol. 2005 Mar;160(1-2):102-9
references.pmid: 15710463
references.citation: Eur J Neurosci. 2006 Dec;24(11):3017-25
references.pmid: 17156363